British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:British Columbia Cancer Agency - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011923
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy, chemotherapy services, nursing care, patient and family counseling, nutrition counseling, pharmacy services, pain and symptom control service, teaching and applied research activities and cancer information library. Its cancer care program includes prevention, screening and early detection, diagnosis and treatment services, support programs, community programs, research and education. BC Cancer Agency partners with communities to provide a network of chemotherapy clinics. It operates through its various centers across Canada. BC Cancer Agency is headquartered in Vancouver, British Columbia, Canada.

British Columbia Cancer Agency – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
British Columbia Cancer Agency, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
British Columbia Cancer Agency, Medical Devices Deals, 2011 to YTD 2017 9
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Zymeworks Enters into Research Agreement with University of Victoria and BC Cancer Agency 11
Charles River Labs Enters into Agreement with British Columbia Cancer Agency 12
Licensing Agreements 13
Coastal Genomics Enters Into Licensing Agreement With BC Cancer Agency For Liquid Handling Automation Technology 13
British Columbia Cancer Agency – Key Competitors 14
British Columbia Cancer Agency – Key Employees 15
British Columbia Cancer Agency – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Oct 05, 2017: Better understanding of bladder cancer subtypes might lead to improved treatments 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Key Facts 2
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
British Columbia Cancer Agency, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
British Columbia Cancer Agency, Deals By Therapy Area, 2011 to YTD 2017 8
British Columbia Cancer Agency, Medical Devices Deals, 2011 to YTD 2017 9
British Columbia Cancer Agency, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Zymeworks Enters into Research Agreement with University of Victoria and BC Cancer Agency 11
Charles River Labs Enters into Agreement with British Columbia Cancer Agency 12
Coastal Genomics Enters Into Licensing Agreement With BC Cancer Agency For Liquid Handling Automation Technology 13
British Columbia Cancer Agency, Key Competitors 14
British Columbia Cancer Agency, Key Employees 15
British Columbia Cancer Agency, Other Locations 16

★海外企業調査レポート[British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • P. H. Glatfelter Co (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Co (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Asian American Medical Group Ltd (AJJ):企業の財務・戦略的SWOT分析
    Asian American Medical Group Ltd (AJJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Terumo Cardiovascular Systems Corporation:医療機器:M&Aディール及び事業提携情報
    Summary Terumo Cardiovascular Systems Corporation (TCSC), a subsidiary of Terumo Corporation, is a provider of medical equipment and devices for cardiac and vascular surgeries. It produces hardware products including heart-lung machines and intra-operative monitoring systems for cardiac surgeries. I …
  • China Energy Conservation and Environmental Protection Group-エネルギー分野:企業M&A・提携分析
    Summary China Energy Conservation and Environmental Protection Group (CECEP) is a clean technology company that offers energy conservation, emission reduction and environment protection services. The company provides clean energy, energy saving, environmental protection, integrated services and reso …
  • Total Petrochemicals & Refining USA Inc:企業の戦略的SWOT分析
    Total Petrochemicals & Refining USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • AAC Technologies Holdings Inc. (2018):企業の財務・戦略的SWOT分析
    AAC Technologies Holdings Inc. (2018) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • VP Bank AG (VPBN):企業の財務・戦略的SWOT分析
    Summary VP Bank AG (VP Bank) is a financial service provider that offers banking services, asset management, and portfolio advisory services to institutional and private investors. The company provides a wide variety of house solutions, third-party financial products through a network of strategical …
  • Cofidis Participations S.A.:企業の戦略・SWOT・財務分析
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hanwha Techwin Co Ltd:企業の戦略・SWOT・財務情報
    Hanwha Techwin Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hanwha Techwin Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • University of Sheffield:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Sheffield (Sheffield University) is an educational service provider that offers undergraduate, postgraduate, research and certificate programmes. The university offers courses in various fields including arts and humanities, engineering, medicine, dentistry and health; social s …
  • InCarda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InCarda Therapeutics Inc (InCarda) is a biopharmaceutical company that concentrates on the development of transformative therapies for cardiovascular conditions through the inhalation route. The company’s lead product candidate includes InRhythm, an inhaled antiarrhythmic for acute treatment …
  • ERHC Energy Inc (ERHE):企業の財務・戦略的SWOT分析
    Summary ERHC Energy Inc (ERHC Energy) is an exploration and production company that explores oil and gas assets. The company possesses deep water oil and gas exploration and production interests in the Gulf of Guinea and onshore interests in Republic of Chad and Republic of Kenya. It holds interests …
  • EQT Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    EQT Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary EQT Corp (EQT) is an integrated oil and gas company. It operates production fields in Marcellus, Upper Devonian, Ohio Utica and other plays in Appalachian Basin. The company produces and markets natural gas …
  • The Lubrizol Corporation:企業の戦略・SWOT・財務情報
    The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report Summary The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MGM China Holdings Ltd:企業の戦略・SWOT・財務情報
    MGM China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary MGM China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Printpack Inc:企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • ARUP Laboratories:医療機器:M&Aディール及び事業提携情報
    Summary ARUP Laboratories (ARUP) is a clinical and anatomical pathology reference laboratory. It is a nonprofit enterprise of the University of Utah and its Department of Pathology. The company provides several tests and test combinations in the fields of anatomic pathology, genetics, pain managemen …
  • Do & Co Poland Sp.Z.O.O
    Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report Summary Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Carna Biosciences Inc (4572):製薬・医療:M&Aディール及び事業提携情報
    Summary Carna Biosciences Inc (Carna) is a biotechnology company that discovers and develops drugs for the treatment of cancer and inflammatory diseases. The company offers products such as kinase proteins, biotinylated kinases, substrates, assay kits, protein substrates, inactive kinases, inactive- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆